CAH
NYSECardinal Health, Inc.
Consumer Defensive · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Research view
Fundamentals · SEC EDGAR · FY 2025-06-30
Revenue & Earnings — fiscal year
$162.5B
2021
$181.3B
2022
$205.0B
2023
$226.8B
2024
$222.6B
2025
Snapshot
SEC EDGAR · FY 2025-06-30Revenue$222.6B
Net Income$1.6B
Gross Profit$8.2B
Oper Income$2.3B
EPS (dil)$6.45
Rev/sh$945.87
FCF/sh$7.86
Book/sh$-11.19
Gross M3.7%
Oper M1.0%
Profit M0.7%
FCF M0.8%
ROE-59.6%
ROA3.0%
ROIC—
R&D/Rev—
Rev Y/Y-1.9%
Rev 3Y CAGR7.1%
EPS Y/Y87.0%
EPS 3Y CAGR—
FCF 3Y CAGR-12.8%
Payout32%
Div/sh—
Shs Chg Y/Y-2%
Current Ratio0.94
Quick Ratio0.50
Debt/Eq-1.08
Int Coverage10.6×
Net Debt$1.0B cash
Total Debt$2.8B
Cash & Eq$3.9B
Total Assets$53.1B
Oper CF$2.4B
Capex$547.0M
Free CF$1.9B
Buybacks$765.0M
Equity$-2.6B
Liabilities—
Shs Outstand0.24B
SectorConsumer Defensive
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $162.5B | $181.3B | $205.0B | $226.8B | $222.6B |
| Gross Profit | $6.8B | $6.5B | $6.9B | $7.4B | $8.2B |
| Operating Income | $472.0M | $-607.0M | $752.0M | $1.2B | $2.3B |
| Net Income | $612.0M | $-937.0M | $331.0M | $853.0M | $1.6B |
| Diluted EPS | $2.08 | $-3.37 | $1.26 | $3.45 | $6.45 |
| Operating Cash Flow | $2.4B | $3.2B | $2.8B | $3.8B | $2.4B |
| Free Cash Flow | $2.0B | $2.8B | $2.4B | $3.3B | $1.9B |
COMMUNITY · $CAH0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.